BC Cancer REB expects that all studies submitted for initial review conform to the ICF template, and specifically, include all language and/or sections marked as mandatory.

Important: Ensure that you are using the current version by returning to this page for templates as needed.

Clinical/Interventional Studies

The Clinical ICF was reviewed by the PHSA legal department updated in March 2022 (see Notice: Informed consent documents).

• BC Cancer Clinical ICF Template v5 (March 2022)
• BC Cancer Clinical ICF Template Instructions (March 2022)

Use the form below to document participants' wishes upon their decision to withdraw from a research study. BC Cancer REB's position is that the participants' wishes should not be obtained at the time of initial ICF signing, but should be obtained once they express a desire to withdraw.

• BC Cancer REB Participant Withdrawal.Sample Document for Study Team - Resource Only.docx

Non-Interventional Studies

• BC Cancer Non interventional Studies ICF Template v2 (August 2020)

Biobanks

• Protocol template: BC Cancer BBRS Biobank protocol template (June 2021) (Word doc)
• ICF template: BC Cancer Biobank ICF Template v3 (August 2020) (Word doc)

Behavioral Studies

• See the PHSA Survey ICF Template.

Please refer to the UBC Behavioural Research Ethics Board (BREB) website for assistance with behavioural studies.

For studies using other institutions' templates but being submitted to the BC Cancer REB for review, please:

Replace contact information with BC Cancer contact:
"For questions about your rights as a research participant or privacy related questions, you can contact BC Cancer Research Ethics at reb@bccancer.bc.ca, or 604.877.6284. Please reference the study number Hxx-xxxxx when contacting Research Ethics so staff can better assist you. "

Insert the following wording when collecting information from participants:
"Federal and provincial privacy laws give safeguards for privacy, security, and authorized access to information. We will not give information that identifies you to anyone without your permission, except as required by law."

E-Consent

BC Cancer REB supports the use of the PHSA/BC Children's/BC Women's REDCap platform for use in research projects that are not regulated clinical trials. Please see below guidance for more information on e-consent:

• BC Cancer Research Ethics Guidance on E-Consent (July 2020) (PDF)

Please note that the use of e-consent for Health Canada and FDA-regulated clinical trials requires specific considerations (see document page 3).